Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Ancilia Biosciences
Company Name
Main Industry
Research & Development, Business Services
Website
www.anciliabio.comAncilia Biosciences is developing virus-resistant live bacterial products for human health and other applications. The company aims to overcome a major obstacle to the success of these productsthe failure to address the role of predatory viral bacteriophages in limiting their effectiveness. The companys proprietary enabling technologies identify and characterize viral phages and leverage the natur al function of CRISPR to produce a new class of live biotherapeutics and other microbial products with immunity to key viral pathogens. Ancilia has obtained both issued and pending patents for its technologies. The company is headquartered in New York City and its founders and advisors include scientific leaders across CRISPR and the virome.
...Read MoreAncilia Biosciences
Headquarters
$1.3 M
9
2019
Ancilia Biosciences raised a total of $4.2 M in funding over 1 rounds.
Here's a list of some of the top trending technologies and APIs used by Ancilia Biosciences.
(2 Technologies)
(2 Technologies)
(2 Technologies)
(1 Technologies)
(1 Technologies)
Parameter | Sample Email | Percentage | |
---|---|---|---|
1 | first | John@anciliabio.com | |
2 | first.last | John.Smith@anciliabio.com | |
3 | first + last | JohnSmith@anciliabio.com | |
4 | first_last | John_Smith@anciliabio.com | |
5 | last | Smith@anciliabio.com |
Company | Employees | Revenue | Top technologies |
---|---|---|---|
Aqtual | 15 | $3 M | |
Output Biosciences | 5 | $3 M | |
Rezq Bio | 5 | $4.8 M | |
Elastrin Therapeutics | 4 | $2.5 M | |
Ana Maria Moise | 6 | $969 K |